Stephanie Okey
Patrimonio netto: 919 941 $ in data 31/07/2026
Patrimonio netto: 919 941 $ in data 31/07/2026
Ms. Stephanie S.
Okey is an Independent Director at Crinetics Pharmaceuticals, Inc. and an Independent Director at PTC Therapeutics, Inc. She is on the Board of Directors at Crinetics Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Ms. Okey was previously employed as an Independent Director by Catalent, Inc., an Independent Director by Albireo Pharma, Inc., and a GM-Rare Disease Business Unit & Senior VP by Genzyme Corp.
She also served on the board at Orphazyme A/S and California Life Sciences Association.
She received her undergraduate degree from The Ohio State University and a graduate degree from Wright State University (Ohio).
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/07/2026 | 6.400 ( 0,01% ) | 534 528 $ | 31/07/2026 | |
| 10/04/2026 | 5.667 ( 0,01% ) | 385 413 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PTC THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/12/2018 |
| CRINETICS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 15/07/2019 |
| Società | Posizione | Fine |
|---|---|---|
| CATALENT, INC. | Direttore/Membro del Consiglio | 18/12/2024 |
| ALBIREO PHARMA, INC. | Direttore/Membro del Consiglio | 02/03/2023 |
| STRATEGIC PARTNERS A/S | Direttore/Membro del Consiglio | 23/05/2022 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Direttore/Membro del Consiglio | 01/01/2016 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/07/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wright State University (Ohio)
Wright State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Catalent, Inc.
Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale